Skip to main content
Clinical Trials/CTRI/2023/10/058410
CTRI/2023/10/058410
Not yet recruiting
Phase 4

An Open Label, Single arm Clinical Study to Evaluate the efficacy of Ambic Chahel Tablets in patients having Stress Issues - NI

Ambic Ayurved India Pvt. Ltd.0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Ambic Ayurved India Pvt. Ltd.
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Pms

Investigators

Sponsor
Ambic Ayurved India Pvt. Ltd.

Eligibility Criteria

Inclusion Criteria

  • 1\.Subject from 18\-65 years of age.
  • 2\.Subject suffering from one or multiple mental health Issues from\- anxiety, insomnia, depression etc;
  • 3\.Subjects that are able to give written informed consent in a manner approved by the institutional ethics committee and comply with the requirements of the study.
  • 4\.Subject willing to avoid participation in any other interventional clinical trial for the duration of the study.

Exclusion Criteria

  • 1\.Have used, are using, or are planning to use immunosuppressive or immunomodulatory medication (i.e., biologics), including oral or parenteral corticosteroids.
  • 2\.Subjects that have participated in any other interventional clinical trial in the previous 30 days.
  • 3\.Subjects with known sensitivity to any of the constituents of the investigational product.

Outcomes

Primary Outcomes

Not specified

Similar Trials